Claire Fletcher

| Imperial College London

Awarded a PhD in prostate cancer molecular biology in 2013. In 2016 granted a Young Investigator Award from the Prostate Cancer Foundation (US) and in 2018, an Imperial College/AstraZeneca Research Fellowship. She is currently establishing an independent research team within the Department of Surgery and Cancer at Imperial, to investigate functions of non-coding RNAs in hormone-dependent cancers and drug resistance, the role of obesity and peri-prostatic adipocytes in promoting lethal prostate cancer and post-transcriptional RNA modifications in modulating therapy response.